Ghost Tree Capital, LLC Vista Gen Therapeutics, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.88 - $1.73 $1.16 Million - $2.28 Million	-1,315,154 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.14 - $2.09 $780,724 - $1.43 Million	-684,846 Reduced 34.24%	1,315,154 $1.63 Million
Q2 2021 Aug 11, 2021	SELL	$1.96 - $3.15 $4.2 Million - $6.75 Million	-2,143,702 Reduced 51.73%	2,000,000 $6.3 Million
Q1 2021 May 14, 2021	BUY	$1.89 - $2.96 $3.22 Million - $5.04 Million	1,703,702 Added 69.82%	4,143,702 $8.83 Million
Q4 2020 Feb 16, 2021	BUY	$0.65 - $1.94 $1.59 Million - $4.73 Million	2,440,000 New	2,440,000 $4.73 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.